Featuring CEO Interview with Michael J. Daley, PhD, President & CEO, OrthogenRX
Volume 2, Number 7
Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.
CEO Leadership Series: Michael J. Daley, PhD, President & CEO, OrthogenRX, Inc.
Dr. Michael Daley used his dynamic experience to lead OrthogenRx in achieving FDA approval of their Class III medical device, GenVisc 850, for the treatment of osteoarthritis knee pain in just 20 months.
CMO Steps in to Prepare Biopharma Company for Q1 IPO
Our client, a start-up biopharma specializing in novel antibiotics, had multiple compounds at various levels of development. The company was targeting a Q1 IPO and required an experienced professional to fill the role of interim CMO. After a successful offering, they could bring that person on permanently.
Interim employment could prove to be a major change for an individual who is used to working for one company over several years. Executives that work on an interim basis are in-demand in the life sciences industry. When should you consider making the professional change to interim in your career? Find out!
Go beyond the news… Get more focused information about your industry and hiring trends. Click now to enhance your subscription.
Biotech Firms Need Innovation Strategies
In the Harvard Business Review, Gary P. Pisano, Ph.D., explained why companies need to create innovation strategies and constantly evolve these strategies. According to Dr. Pisano, there are four innovation strategy types…
Pharmaceutical companies are experimenting with a variety of digital initiatives, but many find it hard to determine what to focus on. Current trends indicate four main areas where digital developments will drive value for pharma companies.
According to PharmaExec.com, quality needs to become more of a focus in biopharma organizations. Leaders should put manufacturing quality at the center of their competitive strategies and, therefore, inspire a culture of quality. The results will exceed all standards…
Life Science Companies Target Emerging Markets In 2015
As competition between life science companies intensifies, traditional markets – especially those in the Unites States – are beginning to see secondary markets catch up. Suburbs are becoming more and more popular for companies as rents increase and specialized labor talent demand higher wages…
